Neoleukin Therapeutics Stock Filter Stocks by Fundamentals
NLTXDelisted Stock | USD 13.96 0.16 1.16% |
Neoleukin Therapeutics fundamentals help investors to digest information that contributes to Neoleukin Therapeutics' financial success or failures. It also enables traders to predict the movement of Neoleukin Stock. The fundamental analysis module provides a way to measure Neoleukin Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Neoleukin Therapeutics stock.
Neoleukin |
Did you try this?
Run Bollinger Bands Now
Bollinger BandsUse Bollinger Bands indicator to analyze target price for a given investing horizon |
All Next | Launch Module |
Neoleukin Fundamentals
Return On Equity | -0.38 | |||
Return On Asset | -0.19 | |||
Current Valuation | (35.02 M) | |||
Shares Outstanding | 2.35 M | |||
Shares Owned By Insiders | 16.46 % | |||
Shares Owned By Institutions | 45.58 % | |||
Number Of Shares Shorted | 26.4 K | |||
Price To Earning | (4.60) X | |||
Price To Book | 0.44 X | |||
EBITDA | (56.48 M) | |||
Net Income | (57.56 M) | |||
Cash And Equivalents | 116.46 M | |||
Cash Per Share | 2.73 X | |||
Total Debt | 12.07 M | |||
Debt To Equity | 0.11 % | |||
Current Ratio | 12.78 X | |||
Book Value Per Share | 34.18 X | |||
Cash Flow From Operations | (45.61 M) | |||
Short Ratio | 1.70 X | |||
Earnings Per Share | (12.28) X | |||
Price To Earnings To Growth | (0.03) X | |||
Target Price | 1.5 | |||
Beta | 1.1 | |||
Market Capitalization | 8.2 M | |||
Total Asset | 115.95 M | |||
Retained Earnings | (451.06 M) | |||
Working Capital | 88.07 M | |||
Current Asset | 289 K | |||
Current Liabilities | 1.02 M | |||
Z Score | -5.73 | |||
Net Asset | 115.95 M |
About Neoleukin Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Neoleukin Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Neoleukin Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Neoleukin Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Neoleukin Stock
If you are still planning to invest in Neoleukin Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neoleukin Therapeutics' history and understand the potential risks before investing.
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |